Ideas to action: independent research for global prosperity
The Case for Globalization and Robust Global Value Chains
February 08, 2024
A New Vintage of Populism in Latin America
February 23, 2024
WASHing Away Resistance: Why the UK Should Invest in Water, Sanitation, and Hygiene to Tackle Antimicrobial Resistance
October 19, 2022
This note was first published as evidence submitted to the joint inquiry of the UK All-Party Parliamentary Groups (APPGs) on WASH and Antibiotics into the links between antibiotic resistance and lack of access to WASH.
Leveraging Purchasing Systems to Ensure Access, Stewardship, and Innovation: A Landscape Review of Current and Potential Market Structures for Antimicrobials
June 28, 2022
This working paper aims to synthesise existing research and thinking on how antimicrobials are procured and ways to improve the current purchasing system.
Understanding the Cost-Effectiveness of COVID-19 Vaccination in Nigeria
April 28, 2022
COVID-19 has disrupted health systems across the globe. Nigeria reported its first COVID-19 case in February 2020, and, since then, the government has rolled out four vaccines to help control the pandemic—Moderna, Oxford-Astra Zeneca (AZ), Johnson & Johnson (J&J) and Pfizer-BioNTech.
Understanding the Cost-Effectiveness of COVID-19 Vaccination in Ethiopia
April 28, 2022
COVID-19 radically changed most people’s lives in 2020, including across Africa. In Ethiopia, the disruption started with school closing, and other restrictions soon followed. Despite these efforts to contain the virus, Ethiopia—like almost all countries—suffered significant health impacts. It has r...
COVID-19 Vaccine Predictions: Using Mathematical Modelling and Expert Opinions to Estimate Timelines and Probabilities of Success of COVID-19 Vaccines
October 01, 2020
We collected publicly available information, interviewed experts, and used our diverse range of expertise to analyse and model the COVID-19 vaccine portfolio in order to generate predictions about the vaccine portfolio's timeline.